Patents by Inventor Shinya Nishiwaki

Shinya Nishiwaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110207655
    Abstract: [Problem]A compound useful for the prevention and/or treatment of chronic obstructive pulmonary disease (COPD) or asthma, and a pharmaceutical composition containing the compound as an active ingredient are provided. [Means for Solution]The present inventors have made extensive studies on the pharmacological actions of naturally fermented materials, and as a result, they have found that a cyclic depsipeptide compound derived from a soil bacterium belonging to the genus Chromobacterium which is collected in Okutama-machi, Tokyo has both an inhibitory action on airway contraction and an inhibitory action on airway inflammation, and thus, is useful as an agent for preventing or treating COPD or asthma, thereby completing the present invention.
    Type: Application
    Filed: October 23, 2009
    Publication date: August 25, 2011
    Applicant: Astellas Pharma Inc.
    Inventors: Susumu Tsujimoto, Masatoshi Taniguchi, Yoshitaka Hirayama, Jun Takasaki, Tomihisa Kawasaki, Kazutoshi Sakamoto, Shinya Nishiwaki, Yukihiro Kitanaga
  • Publication number: 20110105420
    Abstract: [Object] Disclosed is a compound useful as an active ingredient for a pharmaceutical composition having an ?-amylase inhibitory activity, particularly a pharmaceutical composition for the treatment of diabetes. [Solution] An investigation has been made on a compound having an ?-amylase inhibitory activity among the compounds produced by Streptomyces sp. strain 6982, which is a actinomycetes belonging to the genus Streptomyces, and it was confirmed that an aminosugar compound has an ?-amylase inhibitory activity, thus completing the invention. The aminosugar compound of the present invention has an ?-amylase-inhibitory activity, and therefore can be used as a prophylactic or therapeutic agent for diabetes, obesity, NASH (non-alcoholic steatohepatitis), particularly as an ameliorating agent for postprandial blood glucose elevation.
    Type: Application
    Filed: April 9, 2009
    Publication date: May 5, 2011
    Applicant: Astellas Pharma Inc.
    Inventors: Satoshi Sasamura, Hiromi Sasamura, Shinya Nishiwaki